These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33189817)

  • 1. The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery.
    Lang Y; Chen K; Li Z; Li H
    Life Sci; 2021 Oct; 282():118754. PubMed ID: 33189817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review.
    Kaul R; Paul P; Kumar S; Büsselberg D; Dwivedi VD; Chaari A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication.
    Su M; Shi D; Xing X; Qi S; Yang D; Zhang J; Han Y; Zhu Q; Sun H; Wang X; Wu H; Wang M; Wei S; Li C; Guo D; Feng L; Sun D
    J Virol; 2021 Jul; 95(16):e0018721. PubMed ID: 34037422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
    Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling potential inhibitors targeting the nucleocapsid protein of SARS-CoV-2: Structural insights into their binding sites.
    Kumari S; Mistry H; Bihani SC; Mukherjee SP; Gupta GD
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):133167. PubMed ID: 38885868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
    Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
    Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
    [No Abstract]   [Full Text] [Related]  

  • 10. Corona virus versus existence of human on the earth: A computational and biophysical approach.
    Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A
    Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity.
    Wang L; Sola I; Enjuanes L; Zuñiga S
    mBio; 2021 Oct; 12(5):e0131621. PubMed ID: 34517762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents.
    Tatar G; Ozyurt E; Turhan K
    Biotechnol Prog; 2021 Mar; 37(2):e3110. PubMed ID: 33314794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2.
    Wang YT; Long XY; Ding X; Fan SR; Cai JY; Yang BJ; Zhang XF; Luo RH; Yang L; Ruan T; Ren J; Jing CX; Zheng YT; Hao XJ; Chen DZ
    Eur J Med Chem; 2022 Jan; 227():113966. PubMed ID: 34749200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and Nature-Derived Products Targeting Human Coronaviruses.
    Vougogiannopoulou K; Corona A; Tramontano E; Alexis MN; Skaltsounis AL
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
    Wong NA; Saier MH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.